NYSE · CIK 0000217346
TXT TEXTRON INC
Insider trading from SEC Form 4. Last filing Jul 29, 2025. Close $74.16 on Oct 9, 2026, +2% from the 52-week low and -26% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at TEXTRON INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Julie G Duffy EVP and CHRO sell | $2.3M 28,543 shares | -65% | +31% from low-12% from high | |
| 29Weak | Mark S Bamford VP & Corporate Controller sell | $543k 7,451 shares | -31% | - |
Congressional trades
7 trades in TXT disclosed by members of Congress under the STOCK Act. All congressional trades.
- Lisa C. McClainHouse · R-MI · last Nov 21, 20252 bought
2 sold - Alan ArmstrongSenate · R-OK · last Jul 21, 20261 bought
0 sold - Dan NewhouseHouse · R-WA · last Jan 15, 20261 bought
0 sold - Robert P. Bresnahan, Jr.House · R-PA · last Mar 27, 20250 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Alan Armstrong Senate · R-OK | Purchase | TXT Textron Inc. Common Stock | $1,001 to $15k | Mar 27 / Jul 21 116 days after the trade | eFD |
Dan Newhouse House · R-WA | Purchase | TXT Textron Inc. Common Stock | $1,001 to $15k | Dec 11, 2025 / Jan 15 35 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | TXT Textron Inc. Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | TXT Textron Inc. Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | TXT Textron Inc. Common Stock | $1,001 to $15k | Oct 31, 2025 / Nov 21, 2025 21 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | TXT Textron Inc. Common Stock | $1,001 to $15k | Aug 4, 2025 / Sep 12, 2025 39 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Sale | TXT Textron Inc. Common Stock | $1,001 to $15k | Feb 25, 2025 / Mar 27, 2025 30 days after the trade | Clerk |
Transactions
The last 37 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | Julie G Duffy EVP and CHRO | MOption exercise Common Stock | +6,260 | $49.58 | $310k | 43,884 | Jul 29, 2025 |
| Jul 25, 2025 | Julie G Duffy EVP and CHRO | SOpen-market sale Common Stock | -6,260 | $79.40 | $497k | 37,624 | Jul 29, 2025 |
| Jul 25, 2025 | Julie G Duffy EVP and CHRO | MOption exercise Common Stock | +22,283 | $40.60 | $905k | 59,907 | Jul 29, 2025 |
| Jul 25, 2025 | Julie G Duffy EVP and CHRO | SOpen-market sale Common Stock | -22,283 | $79.36 | $1.8M | 37,624 | Jul 29, 2025 |
| Jul 25, 2025 | Julie G Duffy EVP and CHRO | GGift Common Stock | -585 | $0.00 | $0 | 37,039 | Jul 29, 2025 |
| Jul 25, 2025 | Julie G Duffy EVP and CHRO | MOption exercise Employee Stock Option (Right to Buy)derivative | -6,260 | - | - | 0 | Jul 29, 2025 |
| Jul 25, 2025 | Julie G Duffy EVP and CHRO | MOption exercise Employee Stock Option (Right to Buy)derivative | -22,283 | - | - | 0 | Jul 29, 2025 |
| Apr 23, 2025 | Deborah L James director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 18,442 | Apr 25, 2025 |
| Apr 23, 2025 | Maria T Zuber director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 18,446 | Apr 25, 2025 |
| Apr 23, 2025 | Lionel L Nowell III director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 18,430 | Apr 25, 2025 |
| Apr 23, 2025 | Robert Mionis director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 3,115 | Apr 25, 2025 |
| Apr 23, 2025 | Thomas A Kennedy director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 7,801 | Apr 25, 2025 |
| Apr 23, 2025 | Michael X Garrett director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 6,537 | Apr 25, 2025 |
| Apr 23, 2025 | R Kerry Clark director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 9,067 | Apr 25, 2025 |
| Apr 23, 2025 | Kathleen M Bader director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 6,550 | Apr 25, 2025 |
| Apr 23, 2025 | Richard F Ambrose director | AGrant or award Common Stock | +2,794 | $0.00 | $0 | 9,241 | Apr 25, 2025 |
| Mar 31, 2025 | James L Ziemer director | AGrant or award Deferred Stock Unitsderivative | +50 | $74.84 | $3,750 | 83,393 | Apr 2, 2025 |
| Mar 1, 2025 | Mark S Bamford VP & Corporate Controller | AGrant or award Common Stock | +1,492 | $0.00 | $0 | 19,715 | Mar 4, 2025 |
| Mar 1, 2025 | Scott C Donnelly Chairman, President & CEO | AGrant or award Common Stock | +47,232 | $0.00 | $0 | 759,183 | Mar 4, 2025 |
| Mar 1, 2025 | Julie G Duffy EVP and CHRO | AGrant or award Common Stock | +4,592 | $0.00 | $0 | 38,675 | Mar 4, 2025 |
| Mar 1, 2025 | Mark S Bamford VP & Corporate Controller | FTax withholding Common Stock | -326 | $74.73 | $24k | 19,389 | Mar 4, 2025 |
| Mar 1, 2025 | Julie G Duffy EVP and CHRO | FTax withholding Common Stock | -1,051 | $74.73 | $79k | 37,624 | Mar 4, 2025 |
| Mar 1, 2025 | Scott C Donnelly Chairman, President & CEO | FTax withholding Common Stock | -16,765 | $74.73 | $1.3M | 742,418 | Mar 4, 2025 |
| Mar 1, 2025 | Mark S Bamford VP & Corporate Controller | AGrant or award Employee Stock Option (Right to Buy)derivative | +4,970 | $0.00 | $0 | 4,970 | Mar 4, 2025 |
| Mar 1, 2025 | Scott C Donnelly Chairman, President & CEO | AGrant or award Employee Stock Option (Right to Buy)derivative | +157,343 | $0.00 | $0 | 157,343 | Mar 4, 2025 |
| Mar 1, 2025 | Julie G Duffy EVP and CHRO | AGrant or award Employee Stock Option (Right to Buy)derivative | +15,298 | $0.00 | $0 | 15,298 | Mar 4, 2025 |
| Jan 1, 2025 | Mark S Bamford VP & Corporate Controller | AGrant or award Cash-Settled Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 20,000 | Mar 4, 2025 |
| Feb 24, 2025 | Mark S Bamford VP & Corporate Controller | MOption exercise Common Stock | +5,451 | $58.24 | $317k | 23,654 | Feb 26, 2025 |
| Feb 24, 2025 | Mark S Bamford VP & Corporate Controller | SOpen-market sale Common Stock | -5,451 | $72.68 | $396k | 18,223 | Feb 26, 2025 |
| Feb 25, 2025 | Mark S Bamford VP & Corporate Controller | MOption exercise Common Stock | +2,000 | $54.43 | $109k | 20,223 | Feb 26, 2025 |
| Feb 25, 2025 | Mark S Bamford VP & Corporate Controller | SOpen-market sale Common Stock | -2,000 | $73.50 | $147k | 18,223 | Feb 26, 2025 |
| Feb 24, 2025 | Mark S Bamford VP & Corporate Controller | MOption exercise Employee Stock Option (Right to Buy)derivative | -5,451 | $0.00 | $0 | 0 | Feb 26, 2025 |
| Feb 25, 2025 | Mark S Bamford VP & Corporate Controller | MOption exercise Employee Stock Option (Right to Buy)derivative | -2,000 | $0.00 | $0 | 4,596 | Feb 26, 2025 |
| Jan 2, 2025 | Mark S Bamford VP & Corporate Controller | AGrant or award Stock Unitsderivative | +79 | $75.79 | $6,001 | 1,045 | Jan 6, 2025 |
| Jan 2, 2025 | Frank T Connor Executive Vice President & CFO | AGrant or award Stock Unitsderivative | +558 | $75.79 | $42k | 11,731 | Jan 6, 2025 |
| Jan 2, 2025 | Scott C Donnelly Chairman, President & CEO | AGrant or award Stock Unitsderivative | +705 | $75.79 | $53k | 18,306 | Jan 6, 2025 |
| Jan 2, 2025 | Julie G Duffy EVP and CHRO | AGrant or award Stock Unitsderivative | +261 | $75.79 | $20k | 2,331 | Jan 6, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Richard F Ambrosedirector
- Kathleen M Baderdirector
- Mark S BamfordVP & Corporate Controller
- R Kerry Clarkdirector
- Frank T ConnorExecutive Vice President & CFO
- Scott C DonnellyChairman, President & CEO
- Julie G DuffyEVP and CHRO
- Michael X Garrettdirector
- Deborah L Jamesdirector
- Thomas A Kennedydirector
- Robert Mionisceo, officer, president, director
- Lionel L Nowell IIIdirector
- James L Ziemerdirector
- Maria T Zuberdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.